Anbiping

About:

Anbiping focuses on R&D, production, and service of pathological diagnostic products.

Website: http://www.gzlbp.com/

Top Investors: Jinshi Investment, ShenZhen GTJA Investment Group, CDF-Capital, Sinopharm Capital, ZD Capital

Description:

Anbiping is a number of reagents and supporting devices have indeed been independently created by Anbiping, which focuses on tumour screening and correct diagnosis. Pathology is the main application department. It has been established that product lines for liquid-based cytology, polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization can be used to screen for and diagnose tumors based on everything from cell morphology to protein expression.